Mace

https://academic.oup.com/jsm/article/21/Supplement_1/qdae001.281/7600971 Abstract Introduction The benefits and risks of testosterone therapy (TT) have been a subject of long-standing debate. The recent TRAVERSE trial demonstrated that men who received TT did not show an increased risk of...

E. David Crawford, MD, sits down with Robert A. Kloner, MD, Ph.D., and Raymond Rosen, MD, to discuss retrospective evidence of PDE5 inhibitors in preventing major adverse cardiac events (MACE) in men. Crawford, Kloner, and Rosen discuss a retrospective study examining occurrences of MACE in men...

Morbidity and mortality in men: Role of androgens (2022) Giuseppe Fallara, Edoardo Pozzi, Christian Corsini, Federico Belladelli, Luca Boeri, Paolo Capogrosso, Francesco Montorsi, Andrea Salonia In this narrative review, we provide an overview of the current literature on male hypogonadism and...